A consortium, consisting Saudi Authority for Data and Artificial intelligence (SDAIA), King Khalid Eye Specialist Hospital (KKESH), Lean Business Services, and Saudi Company for Artificial Intelligence (SCAI) announced the unveiling of “Eyenai,” the first AI-powered ophthalmic solution developed locally by Saudi AI engineers and experts in the field. This groundbreaking advancement in the realm of medical diagnostics in the region represents a significant milestone in the field.

Eyenai is set to become Saudi Arabia's pioneering eye screening solution that harnesses the power of artificial intelligence to precisely detect and diagnose diabetic retinopathy. By leveraging advanced analytics and intelligent algorithms, the solution is designed to simplify and expedite the screening process, addressing the challenges posed by limited resources, time-consuming examinations, and high costs.

Commenting on this launch, Dr. Adi Alowaifeer, Consultant and Assistant Professor of Ophthalmology, Chairman of Eyenai Management Committee, said: "The launch of Eyenai embodies the spirit of ingenuity and cooperation that defines Saudi Arabia's healthcare ecosystem. This solution has the potential to revolutionize diabetic retinopathy screening by making it more accessible, affordable, and accurate. Our collective mission is to safeguard the vision of countless people and improve the overall quality of healthcare in the Kingdom."

The launch of Eyenai marks a significant milestone in the journey towards enhancing the nation's healthcare landscape. By leveraging cutting-edge AI and computer vision technologies, the new solution is setting benchmarks for early detection and intervention in diabetic retinopathy.